https://www.selleckchem.com/products/v-9302.html
No post-treatment tumors were HER2-negative according to DISH in HER2-positive pre-treatment tumors. Among HER2-negative pretreatment tumors, 1 post-treatment tumor was HER2 positive and 2 had stable HER2 status. HER2 status determined by DISH was stable between pretreatment breast tumors and residual tumors. However, a small discrepancy regarding HER2 status determined by immunohistochemistry and DISH existed. HER2 status determined by DISH was stable between pretreatment breast tumors and residual tumors. However, a small discrepancy r
Like
Comment
Share
